Oral gene delivery:: Strategies to improve stability of pDNA towards intestinal digestion

被引:33
作者
Loretz, Brigitta [1 ]
Foeger, Florian [1 ]
Werle, Martin [1 ]
Bernkop-Schnuerch, Andreas [1 ]
机构
[1] Leopold Franzens Univ, Dept Pharmaceut Technol, Inst Pharm, A-6020 Innsbruck, Austria
关键词
enzymatic degradation; DNase inhibitors; chitosan; gene therapy; DNA vaccines;
D O I
10.1080/10611860600823766
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose : Gastrointestinal (GI) nucleases are responsible for a rapid presystemic degradation of orally administered transgenes. Within the current study, the activity of these degrading enzymes as well as the effect of various nuclease inhibitors on the degradation process were evaluated in order to assess their potential as auxiliary agents in oral gene delivery. Methods : Digestion assays of pDNA with DNaseI and in GI juices were performed in absence and presence of inhibitors. Consequently, a chitosan conjugate with covalently bound ethylendiaminetetraacetic acid disodium salt dihydrat (EDTA) was synthesized and its nuclease inhibitory properties were evaluated. Results : Small intestinal juice was shown to possess a nuclease activity per millilitre corresponding to 0.02 Kunitz units of DNaseI. Inhibition studies revealed that inhibitory activity followed the ranking: EDTA > sodium dodecyl sulfate (SDS) > aurintricarboxylic acid (ATA) > poly (acrylic acid) > cysteine. The chitosan-EDTA conjugate offered good nuclease inhibiting properties. Conclusion : This study determined the nuclease activity of native porcine small intestinal juice as well as enterocytes homogenate. Moreover, several promising strategies to overcome this enzymatic barrier were identified.
引用
收藏
页码:311 / 319
页数:9
相关论文
共 20 条
[1]   Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates [J].
Bernkop-Schnurch, A ;
Krajicek, ME .
JOURNAL OF CONTROLLED RELEASE, 1998, 50 (1-3) :215-223
[2]  
BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243
[3]   Efficiency of polyethylenimines and polyethylenimine-graft-poly (ethylene glycol) block copolymers to protect oligonucleotides against enzymatic degradation [J].
Brus, C ;
Petersen, H ;
Aigner, A ;
Czubayko, F ;
Kissel, T .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (03) :427-430
[4]  
Chen J, 2004, WORLD J GASTROENTERO, V10, P112
[5]   Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles [J].
Corsi, K ;
Chellat, F ;
Yahia, L ;
Fernandes, JC .
BIOMATERIALS, 2003, 24 (07) :1255-1264
[6]   DNases and apoptosis [J].
Counis, MF ;
Torriglia, A .
BIOCHEMISTRY AND CELL BIOLOGY, 2000, 78 (04) :405-414
[7]   Chitosan-based nanoparticles for topical genetic immunization [J].
Cui, ZR ;
Mumper, RJ .
JOURNAL OF CONTROLLED RELEASE, 2001, 75 (03) :409-419
[8]   Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability [J].
Erbacher, P ;
Zou, SM ;
Bettinger, T ;
Steffan, AM ;
Remy, JS .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1332-1339
[9]   Stability of polycationic complexes of an antisense oligonucleotide in rat small intestine homogenates [J].
Ferreiroa, MG ;
Crooke, RM ;
Tillman, L ;
Hardee, G ;
Bodmeier, R .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 55 (01) :19-26
[10]   DNA transfection of macaque and murine respiratory tissue is greatly enhanced by use of a nuclease inhibitor [J].
Glasspool-Malone, J ;
Steenland, PR ;
McDonald, RJ ;
Sanchez, RA ;
Watts, TL ;
Zabner, J ;
Malone, RW .
JOURNAL OF GENE MEDICINE, 2002, 4 (03) :323-332